1 citations
,
October 2025 in “Journal of the American Society of Nephrology” COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.
1 citations
,
May 2024 in “Pediatric Blood & Cancer” Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.
1 citations
,
June 2023 in “Advances in therapy” Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.
1 citations
,
April 2022 in “Der Hautarzt” Hair transplantation can permanently and naturally improve hair loss if done by skilled surgeons with proper planning.
1 citations
,
January 2021 in “Elsevier eBooks” Olive and olive oil help prevent and manage heart diseases.
1 citations
,
December 2019 in “Dermatologic Therapy” Only anti-androgenic drugs likely halt AGA progression.
1 citations
,
April 2017 in “Journal of Investigative Dermatology” Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.
1 citations
,
March 2014 in “Applied Microscopy” CK19 and Vimentin are proteins found in rat skin that help with skin renewal and maintaining cell structure.
1 citations
,
September 2011 in “Journal of the American Geriatrics Society” A potential genetic link between Werner syndrome and kidney disease was suggested.
1 citations
,
January 2009 in “Journal of S C C J” Changing disulfide bonds in human hair affects its melting behavior and thermal stability.
July 2026 in “Scholars Journal of Medical Case Reports” Different scalp conditions can coexist and need separate treatments.
July 2026 in “Asian Journal of Pharmaceutical Sciences” The study introduces a novel Janus microneedle (Janus MN) designed for vitiligo treatment, which targets immune regulation, melanocyte regeneration, and melanosome transfer. The microneedle features a core-shell bilayer structure, with the shell containing hypericin-assembled nanoparticles and astragalus polysaccharides to improve the microenvironment by reducing oxidative stress and inhibiting immune attacks on melanocytes. The core, containing stabilized trypsin, activates the PAR2 signaling pathway to enhance melanosome transfer, promoting pigmentation. This approach achieves a multidimensional intervention by integrating dual targets within the epidermis and hair follicles, offering a precise, spatiotemporally sequential treatment strategy for vitiligo.
July 2026 in “International Journal of Homoeopathic Sciences” Homeopathic treatment improved hair health and reduced hair loss.
Insect eggshells form through specialized cell processes and gene regulation, with potential for pest control innovations.
June 2026 in “British Journal of Dermatology” Hairline-lowering surgery may trigger lichen planopilaris in some people.
May 2026 in “SKIN The Journal of Cutaneous Medicine” Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.
MTS and caffeine ampoule improve hair and scalp conditions in women with hairline alopecia.
Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.
April 2026 in “International Journal of Homoeopathic Sciences” Homoeopathic treatment using Opium helped regrow beard hair by addressing mental symptoms.
March 2026 in “Menopause The Journal of The North American Menopause Society” Migraines often worsen during perimenopause, but safe treatments are available.
March 2026 in “Clinical Cosmetic and Investigational Dermatology” Upadacitinib improved multiple immune-related conditions in one patient.
February 2026 in “Clinical Cosmetic and Investigational Dermatology” Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.
February 2026 in “Pediatrics in Review” A newborn with severe low blood sugar due to a genetic issue needed major surgery after standard treatments failed.
January 2026 in “Medico Research Chronicles” Homeopathy may help reduce hair loss and improve hair quality in male pattern baldness.
December 2025 in “International Journal of Innovative Technologies in Social Science” Ritlecitinib is generally safe for long-term use, with mostly mild side effects.
Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.
August 2025 in “Ophthalmic Plastic and Reconstructive Surgery” Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.
July 2025 in “Revista Eletrônica Acervo Científico” Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.
March 2025 in “Frontiers in Plant Science” The ZmNF-YC1–ZmAPRG pathway in maize improves phosphorus efficiency and grain yield, suggesting it as a target for breeding better crops.
March 2025 in “European Journal of Medical Genetics” Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.